Het individualiseren van de dosering van docetaxel door middel van een Microdose.
Recruiting
- Conditions
- English: Breast cancer, prostate cancer, non-small cell lung cancer (NSCLC).Dutch:Borstkanker, prostaatkanker, niet-kleincellig longcarcinoom.
- Registration Number
- NL-OMON28213
- Lead Sponsor
- Initiator = sponsor
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
Patients with breast-, prostate and non-small cell lung cancer, who are planned for routine treatment with docetaxel
Exclusion Criteria
- Absence of informed consent
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pharmacokinetics of a microdose
- Secondary Outcome Measures
Name Time Method The relationship of the pharmacokinetics with therapeutic docetaxel dose pharmacokinetics